Pharmaceutical sector in big trouble

Published: 2011-11-29 06:59:00

Updated: 2011-11-29 06:59:00

The local pharmaceutical sector is reeling from possible impacts of the Korea-US free trade agreement, amid the government’s pressure to cut drug prices.

The real concern lies in the possibility that Korea drug makers will lose out to foreign counterparts in the domestic generic drugs market o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK